Macquarie Group’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.25M | Sell |
242,039
-2,945
| -1% | -$27.3K | ﹤0.01% | 1186 |
|
|
2025
Q1 | $1.8M | Buy |
244,984
+234,436
| +2,223% | +$1.72M | ﹤0.01% | 1255 |
|
|
2024
Q4 | $90 | Buy |
+10,548
| New | +$90 | ﹤0.01% | 1628 |
|
|
2022
Q2 | – | Sell |
-8,837
| Closed | -$44 | – | 2601 |
|
|
2022
Q1 | $44 | Hold |
8,837
| – | – | ﹤0.01% | 2177 |
|
|
2021
Q4 | $62K | Sell |
8,837
-2,149
| -20% | -$15.1K | ﹤0.01% | 2083 |
|
|
2021
Q3 | $110K | Buy |
10,986
+7,396
| +206% | +$74.1K | ﹤0.01% | 1951 |
|
|
2021
Q2 | $51K | Buy |
3,590
+2,406
| +203% | +$34.2K | ﹤0.01% | 2155 |
|
|
2021
Q1 | $19K | Sell |
1,184
-562
| -32% | -$9.02K | ﹤0.01% | 2296 |
|
|
2020
Q4 | $36K | Buy |
+1,746
| New | +$36K | ﹤0.01% | 2112 |
|
|
2018
Q1 | – | Sell |
-6,900
| Closed | -$31K | – | 2311 |
|
|
2017
Q4 | $31K | Buy |
+6,900
| New | +$31K | ﹤0.01% | 2141 |
|